|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.415 AUD | +2.47% |
|
-3.49% | -12.63% |
MGC Pharmaceuticals Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 0.599534 million compared to AUD 2.66 million a year ago. Net loss was AUD 7.08 million compared to AUD 10.88 million a year ago.
Basic loss per share from continuing operations was AUD 0.3064 compared to AUD 4.2 a year ago. Diluted loss per share from continuing operations was AUD 0.3064 compared to AUD 4.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.63% | 12.25M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
ARGENT BIOPHARMA LIMITED 
